{"id":11246,"date":"2019-10-04T00:00:00","date_gmt":"2019-10-04T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/"},"modified":"2025-08-19T08:28:21","modified_gmt":"2025-08-19T13:28:21","slug":"daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/","title":{"rendered":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE"},"content":{"rendered":"<p>Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur.<\/p>\n<p><a href=\"https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/pcodr_profund_daratumumab_darzalex_mm_2ln_beyond.pdf\" target=\"_blank\" rel=\"noopener\">Tous les d\u00e9tails<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11246","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11246"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246\/revisions"}],"predecessor-version":[{"id":31325,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246\/revisions\/31325"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}